Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Total Liabilities ₹3,193 Cr₹4,520 Cr₹3,012 Cr₹3,023 Cr₹7,804 Cr

What is the latest Total Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹3,193 Cr based on Mar2023 Consolidated results.
Year Total Liabilities
Mar2023₹3,193 Cr
Mar2022₹4,520 Cr
Mar2021₹3,012 Cr
Mar2020₹3,023 Cr
Mar2019₹7,804 Cr

How is Total Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2023 ₹3,193 Cr
-29.36
Mar2022 ₹4,520 Cr
50.09
Mar2021 ₹3,012 Cr
-0.37
Mar2020 ₹3,023 Cr
-61.27
Mar2019 ₹7,804 Cr -

Compare Total Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹38,818.9 Cr 14.7% 20.6% 58.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr 0.4% -0.4% 61.2% Stock Analytics
CIPLA ₹112,990.0 Cr -1.1% 1.7% 53.9% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 5.9% 11.3% 94.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr -0.1% 3.9% 20% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -2% -4.2% 29.3% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

14.7%

20.6%

58.1%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses